Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Adial Pharmaceuticals Inc (ADIL)
NASDAQ:ADIL
RESEARCH TOOLSreports
Adial Pharmaceuticals (ADIL) Stock Price & Analysis
414 Followers
ADIL Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.77 - $8.88
Previous Close$1.09
Volume15.45K
Average Volume (3M)161.50K
Market Cap
$4.61M
Enterprise Value$1.79M
Total Cash (Recent Filing)$2.83M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta0.65
Next Earnings
Nov 12, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-5.88
Shares Outstanding4,233,308
10 Day Avg. Volume142,395
30 Day Avg. Volume161,497
Standard Deviation0.32
R-Squared0.05
Alpha-0.03
Financial Highlights & Ratios
Price to Book (P/B)1.16
Price to Sales (P/S)10.54
Price to Cash Flow (P/CF)-1.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue3.97
Enterprise Value/Gross Profit3.97
Enterprise Value/Ebitda-0.26
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Adial Pharmaceuticals News
Ownership Overview
86.42% Insiders
0.35% Mutual Funds
1.84% Other Institutional Investors
11.39% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
ADIL FAQ
What was Adial Pharmaceuticals Inc’s price range in the past 12 months?
Adial Pharmaceuticals Inc lowest stock price was $0.77 and its highest was $8.88 in the past 12 months.
What is Adial Pharmaceuticals Inc’s market cap?
Currently, no data Available
When is Adial Pharmaceuticals Inc’s upcoming earnings report date?
Adial Pharmaceuticals Inc’s upcoming earnings report date is Nov 12, 2024 which is in 113 days.
How were Adial Pharmaceuticals Inc’s earnings last quarter?
Adial Pharmaceuticals Inc released its earnings results on May 10, 2024. The company reported -$2.19 earnings per share for the quarter, missing the consensus estimate of -$0.42 by -$1.77.
Is Adial Pharmaceuticals Inc overvalued?
According to Wall Street analysts Adial Pharmaceuticals Inc’s price is currently Overvalued.
Does Adial Pharmaceuticals Inc pay dividends?
Adial Pharmaceuticals Inc does not currently pay dividends.
What is Adial Pharmaceuticals Inc’s EPS estimate?
Adial Pharmaceuticals Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Adial Pharmaceuticals Inc have?
Adial Pharmaceuticals Inc has 4,233,308 shares outstanding.
What happened to Adial Pharmaceuticals Inc’s price movement after its last earnings report?
Adial Pharmaceuticals Inc reported an EPS of -$2.19 in its last earnings report, missing expectations of -$0.42. Following the earnings report the stock price went down -9.091%.
Which hedge fund is a major shareholder of Adial Pharmaceuticals Inc?
Currently, no hedge funds are holding shares in ADIL
---
Adial Pharmaceuticals Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
ADIL Sentiment 100%
Sector Average 72%
Sector Average 72%
Crowd Wisdom
Positive
Last 7 Days ▲ 0.3%
Last 30 Days ▲ 1.6%
Last 30 Days ▲ 1.6%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-84.74%
12-Months-Change
Fundamentals
Return on Equity
-297.26%
Trailing 12-Months
Asset Growth
71.32%
Trailing 12-Months
Company Description
Adial Pharmaceuticals Inc
Adial Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company, which is focused on the treatment of alcohol use disorder. Its lead product AD04, a selective serotonin-3 antagonist is in Phase 3 clinical trial. The company was founded by Bankole A. Johnson in November 2010 and is headquartered in Charlottesville, VA.
---
ADIL Stock 12 Month Forecast
Average Price Target
―Technical Analysis
Best Analysts Covering ADIL
1 Year
1 Year Success Rate
0/2 ratings generated profit
1 Year Average Return
-46.20%
reiterated a buy rating 5 months ago
Copying Kemp Dolliver's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -46.20% per trade.
---